Role of Trim5α in the Suppression of Cross-Species Transmission and its Defence Against Human Immunodeficiency Virus

被引:4
|
作者
Puvvada, Madhuri P. [1 ]
Patel, Snehal S. [1 ]
机构
[1] Nirma Univ, Inst Pharm, Dept Pharmacol, Ahmadabad, Gujarat, India
关键词
Acquired immunodeficiency syndrome; human immunodeficiency virus; restriction factor; transmission; TRIM5; alpha; MURINE LEUKEMIA VIRUSES; RETROVIRAL RESTRICTION; PRIMATE TRIM5-ALPHA; ANTIVIRAL ACTIVITY; FACTOR TRIMCYP; RHESUS-MONKEY; HIV-1; CYCLOPHILIN; INFECTION; CLONING;
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Acquired Immunodeficiency Syndrome (AIDS) was discovered 30 years ago and was followed by the identification and characterization of its causative agent, Human Immunodeficiency Virus (HIV). Increasing spread of retroviral infections has impelled science to understand the evolution of retroviruses from primates to humans. In the course of evolution, host cells have developed intracellular proteins to counteract the transforming viral defence system. Such inhibitory endogenous intracellular proteins are known as restriction factors. Tripartite motif protein isoform 5 alpha (TRIM5 alpha), Apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like (APOBEC), and Tetherin proteins are few important restriction factors that have been extensively studied. Several evidences have conveyed information regarding specific adaptations occurring in HIV-1 and its relatives to inhibit these host defenses; making the study more interesting. The characteristic potential of restriction factors to restrict the replication of retroviruses was enticing when studies were found that HIV-1 virus cannot infect nonhuman primate species. This review emphasizes on TRIM5 alpha as a restriction factor and its significance in the evolution of retroviruses. It also accentuates the role of polymorphism within the regions of TRIM5 alpha in both human and primate species that eventually affect the cross-species transmission of immunodeficiency viruses.
引用
收藏
页码:601 / 609
页数:9
相关论文
共 27 条
  • [1] TRIM5 Suppresses Cross-Species Transmission of a Primate Immunodeficiency Virus and Selects for Emergence of Resistant Variants in the New Species
    Kirmaier, Andrea
    Wu, Fan
    Newman, Ruchi M.
    Hall, Laura R.
    Morgan, Jennifer S.
    O'Connor, Shelby
    Marx, Preston A.
    Meythaler, Mareike
    Goldstein, Simoy
    Buckler-White, Alicia
    Kaur, Amitinder
    Hirsch, Vanessa M.
    Johnson, Welkin E.
    PLOS BIOLOGY, 2010, 8 (08) : 35 - 36
  • [2] Characterization of TRIM5α trimerization and its contribution to human immunodeficiency virus capsid binding
    Javanbakht, Hassan
    Yuan, Wen
    Yeung, Darwin F.
    Song, Byeongwoon
    Diaz-Griffero, Felipe
    Li, Yuan
    Li, Xing
    Stremlau, Matthew
    Sodroski, Joseph
    VIROLOGY, 2006, 353 (01) : 234 - 246
  • [3] Effects of human TRIM5α polymorphisms on antiretroviral function and susceptibility to human immunodeficiency virus infection
    Javanbakht, Hassan
    An, Ping
    Gold, Bert
    Petersen, Desiree C.
    O'Huigin, Cohn
    Nelson, George W.
    O'Brien, Stephen J.
    Kirk, Gregory D.
    Detels, Roger
    Buchbinder, Susan
    Donfield, Sharyne
    Shulenin, Sergey
    Song, Byeongwoon
    Perron, Michel J.
    Stremlau, Matthew
    Sodroski, Joseph
    Dean, Michael
    Winkler, Cheryl
    VIROLOGY, 2006, 354 (01) : 15 - 27
  • [4] Comparison of anti-viral activity of rhesus monkey and cynomolgus monkey TRIM5αs against human immunodeficiency virus type 2 infection
    Kono, Ken
    Song, Haihan
    Shingai, Yasuhiro
    Shioda, Tatsuo
    Nakayama, Emi E.
    VIROLOGY, 2008, 373 (02) : 447 - 456
  • [5] The Carboxyl-Terminus of Human Immunodeficiency Virus Type 2 Circulating Recombinant form 01_AB Capsid Protein Affects Sensitivity to Human TRIM5α
    Miyamoto, Tadashi
    Nakayama, Emi E.
    Yokoyama, Masaru
    Ibe, Shiro
    Takehara, Shunpei
    Kono, Ken
    Yokomaku, Yoshiyuki
    Pizzato, Massimo
    Luban, Jeremy
    Sugiura, Wataru
    Sato, Hironori
    Shioda, Tatsuo
    PLOS ONE, 2012, 7 (10):
  • [6] Impact of a single amino acid in the variable region 2 of the Old World monkey TRIM5α SPRY (B30.2) domain on anti-human immunodeficiency virus type 2 activity
    Kono, Ken
    Bozek, Katarzyna
    Domingues, Francisco S.
    Shioda, Tatsuo
    Nakayama, Emi E.
    VIROLOGY, 2009, 388 (01) : 160 - 168
  • [7] Recapitulating Cross-Species Transmission of Simian Immunodeficiency Virus SIVcpz to Humans by Using Humanized BLT Mice
    Yuan, Zhe
    Kang, Guobin
    Ma, Fangrui
    Lu, Wuxun
    Fan, Wenjin
    Fennessey, Christine M.
    Keele, Brandon F.
    Li, Qingsheng
    JOURNAL OF VIROLOGY, 2016, 90 (17) : 7728 - 7739
  • [8] A single amino acid substitution of the human immunodeficiency virus type 1 capsid protein affects viral sensitivity to TRIM5α
    Kuroishi, Ayumu
    Bozek, Katarzyna
    Shioda, Tatsuo
    Nakayama, Emi E.
    RETROVIROLOGY, 2010, 7
  • [9] Role of TRIM5α RING Domain E3 Ubiquitin Ligase Activity in Capsid Disassembly, Reverse Transcription Blockade, and Restriction of Simian Immunodeficiency Virus
    Kim, Jonghwa
    Tipper, Christopher
    Sodroski, Joseph
    JOURNAL OF VIROLOGY, 2011, 85 (16) : 8116 - 8132
  • [10] Suppressor of Cytokine Signaling 1 Counteracts Rhesus Macaque TRIM5α-Induced Inhibition of Human Immunodeficiency Virus Type-1 Production
    Sukegawa, Sayaka
    Sakuma, Ryuta
    Ohmine, Seiga
    Takeuchi, Hiroaki
    Ikeda, Yasuhiro
    Yamaoka, Shoji
    PLOS ONE, 2014, 9 (10):